Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Molecular Cell|January 12, 2021
R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m<sup>6</sup>A/PFKP/LDHB axisYing Qing, Lei Dong, Lei Gao, et al.Cancer Cell|December 27, 2016
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N<sup>6</sup>-Methyladenosine RNA DemethylaseZejuan Li, Hengyou Weng, Rui Su, et al.Blood Advances|October 9, 2020
Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentationsSimone Feurstein, Ayodeji Adegunsoye, Danijela Mojsilovic, et al.Nature Communications|April 27, 2016
miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemiaXi Jiang, Chao Hu, Stephen Arnovitz, et al.Blood Advances|January 19, 2018
Heterozygous <i>RTEL1</i> variants in bone marrow failure and myeloid neoplasmsJudith C W Marsh, Fernanda Gutierrez-Rodrigues, James Cooper, et al.Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013
TET1 plays an essential oncogenic role in MLL-rearranged leukemiaHao Huang, Xi Jiang, Zejuan Li, et al.Cancer Cell|October 20, 2012
Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemiaXi Jiang, Hao Huang, Zejuan Li, et al.Nature Communications|April 11, 2018
Publisher Correction: miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemiaZejuan Li, Hao Huang, Ping Chen, et al.Nature Communications|February 23, 2012
miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemiaZejuan Li, Hao Huang, Ping Chen, et al.Blood|January 19, 2012
Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AMLZejuan Li, Hao Huang, Yuanyuan Li, et al.Pageof 7